Lodonal:Immune Therapeutics Files Lodonal New Drug Application ...
Immune Therapeutics Files Lodonal New Drug Application ...
2017年4月25日—(OTCQB:IMUN)isaclinical-stagebiopharmaceuticalcompanydevelopingitsproprietaryversionoflower-dosenaltrexoneLodonalasstandaloneand ...。其他文章還包含有:「BiostaxEX」、「ImmuneTherapeuticssaysNAFDACapprovesLodonal」、「Lodonal(naltrexonelowdoseoral)BiostaxCorp」、「ImmuneTherapeuticsAnnouncesExclusiveAgreement...」、「imun」、「BiostaxCorp」、「Biostax与Immgenuity签署合作协议,寻...
查看更多 離開網站Biostax EX
https://www.biostaxcorp.com
Lodonal is currently approved in Nigeria for the treatment of HIV. The approval is for a one-day Immune System Regulator for the management of HIV/AIDS.
Immune Therapeutics says NAFDAC approves Lodonal
https://www.reuters.com
NAFDAC approved lodonal as over counter, non-toxic adjunct therapy in treatment of HIV/Aids and immune system regulator Source text for ...
Lodonal (naltrexone low dose oral) Biostax Corp
https://delta.larvol.com
The results suggest that low-dose naltrexone is not effective in managing chronic pain and improving the quality of life in patients with diverse chronic pain ...
Immune Therapeutics Announces Exclusive Agreement ...
https://www.biospace.com
Lodonal is an opiate antagonist shown to act as an immune modulator that works by rebalancing and restoring the immune system. Lodonal ...
imun
https://www.sec.gov
IRT-103 is an active immunotherapy drug consisting of 4.5 mg naltrexone hydrochloride, also referred to as Low Dose Naltrexone (LDN) or LODONAL™ (LODONAL).
Biostax Corp
https://www.biostaxcorp.com
Lodonal ™. The Once-a-day Immune System-Regulator for the Management of HIV/AIDS. Committed to the Global Promise to End AIDS by 2030 · Discover Lodonal ...
Biostax 与Immgenuity 签署合作协议,寻求艾滋病毒缓解
https://www.sohu.com
这次合作将充分利用Immgenuity在免疫细胞群识别、免疫逃逸机制等尖端技术方面的专业知识,以及Biostax在使用Lodonal™作为免疫增强和抗炎药物方面的 ...
Immune Therapeutics Announces Filing Acceptance ...
https://www.prnewswire.com
If approved, LodonalTM would be the first affordable non-toxic therapy for the treatment of patients with HIV and cancer. We look forward to ...
Immune Therapeutics
https://www.sec.gov
In several clinical studies, Lodonal™ has been shown to modulate immune system function by decreasing elevated inflammatory responses associated ...